Log in
E-mail
Password
Remember
Forgot password ?
Become a member for free
Sign up
Sign up
Settings
Settings
Dynamic quotes 
OFFON

4-Traders Homepage  >  Equities  >  Nyse  >  Teva Pharma Ind.       

TEVA PHARMA IND.
Mes dernières consult.
Most popular
Report
 SummaryChartsNewsCalendarCompanyFinancialsConsensusRevisions 
Financials ($)
Sales 2017 22 633 M
EBIT 2017 6 276 M
Net income 2017 -
Debt 2017 34 419 M
Yield 2017 -
Sales 2018 20 650 M
EBIT 2018 5 056 M
Net income 2018 -
Debt 2018 27 811 M
Yield 2018 -
P/E ratio 2017 -
P/E ratio 2018
EV / Sales2017 2,45x
EV / Sales2018 2,37x
Capitalization 21 086 M
More Financials
Company
Teva Pharmaceutical Industries Ltd. is a global pharmaceutical company, which provides patient-centric healthcare solutions.It operates through two segments: Generic Medicines and Specialty Medicines.The Generic Medicines segment includes chemical and therapeutic equivalents of originator medicines... 
Sector
Pharmaceuticals
Calendar
02/08 | 01:01pmEarnings Release
More about the company
Latest news on TEVA PHARMA IND.
01/22 TEVA PHARMACEUTICAL INDUSTRIES : asthma drug Phase III trial misses target
01/22 TEVA PHARMACEUTICAL INDUSTRIES : Announces Top-Line Results from Phase III Studi..
01/17 TEVA PHARMACEUTICAL INDUSTRIES : FDA approves Teva leukemia treatment
01/17 TEVA PHARMACEUTICAL INDUSTRIES : U.S. FDA Approves Tevas Trisenox
01/16 TEVA PHARMACEUTICAL INDUSTRIES : Announces U.S. FDA Approval of TRISENOX Injecti..
01/16 TEVA PHARMACEUTICAL INDUSTRIES : Announces U.S. FDA Approval of TRISENOX (arseni..
01/16 TEVA PHARMACEUTICAL INDUSTRIES : Embattled Teva fined NIS 75m. for bribing forei..
01/15 TEVA PHARMACEUTICAL INDUSTRIES : settles graft case with Israeli authorities
01/15 TEVA PHARMACEUTICAL INDUSTRIES : agrees future of Abic Netanya with workers
01/15 TEVA PHARMACEUTICAL INDUSTRIES : corruption settlement doesn't cover co officers
More news
Sector news : Pharmaceuticals - NEC
01/22 WILLIAM ACKMAN : Ackman cuts staff, shuns limelight as he seeks to turn around f..
01/22 TSX dips as railroad and materials shares weigh
01/22 Stocks hit record as senators reach deal to end shutdown
01/22 Canada's small financial firms get buzz from weed stocks
01/22 Big Drugmakers Pay Big Prices for Promising Biotechs
More sector news : Pharmaceuticals - NEC
Chart TEVA PHARMA IND.
Duration : Period :
Teva Pharma Ind. Technical Analysis Chart | 4-Traders
Income Statement Evolution
Consensus
 
Mean consensus OUTPERFORM
Number of Analysts 2
Average target price 23,3 $
Spread / Average Target 12%
Managers
NameTitle
Kåre Schultz President, Chief Executive Officer & Director
Sol J. Barer Chairman
Carlo de Notaristefani President & CEO-Global Operations
Michael McClellan Chief Financial Officer & Executive Vice President
Amir Elstein Independent Director
Sector and Competitors
1st jan.Capitalization (M$)
TEVA PHARMA IND.0.00%21 086
JOHNSON & JOHNSON5.47%395 886
NOVARTIS1.19%227 592
PFIZER1.99%220 189
ROCHE HOLDING LTD.-4.87%211 135
MERCK AND COMPANY8.90%167 132